Labcyte | GenomeWeb

Labcyte

Notable is adopting Labcyte's Echo acoustic liquid handling platform to screen cancer patients' tumor cells for response to individual and combination therapies.

The University's Institute for Molecular Medicine Finland will incorporate Labcyte's Echo acoustic liquid handling technology into multiple workflows.

The funds from Oxford Finance and Silicon Valley Bank will be used for R&D and commercialization of Labcyte's liquid handling systems.

Sample prep firm Labcyte said this week that it has received a $1 million Phase II small business innovation research grant for work on developing the company's acoustic liquid handling system as part of MALDI mass spec workflows.

NEW YORK (GenomeWeb News) – The National Cancer Institute has awarded Labcyte $1 million to create a process for detecting cancer-associated proteins in samples, the company announced today.

NEW YORK (GenomeWeb News) – Labcyte said today that it is collaborating with AstraZeneca on applying its acoustic liquid handling technology to mass spec-based drug discovery work.

Phenomenex this week added 1.3-micron UHPLC columns to its Kinetex core shell product line.

NEW YORK (GenomeWeb News) – Labcyte has reeled in $5.3 million in Series D financing, which it plans to use to expand its acoustic low-volume liquid handling systems, the company said on Tuesday.

NEW YORK (GenomeWeb News) – Labcyte said today that the Institute for Molecular Medicine Finland, known as FIMM, will use Labcyte's acoustic liquid handling technology in its small molecule-based personalized cancer medicine programs, under a new collaboration.

Eppendorf this week launched the Mastercycler Nexus family of PCR instruments.

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.